Gregory Lamar Ford

US Patent:

20120040858, Feb 16, 2012

Filed:

Aug 5, 2011

Appl. No.:

13/204358

Inventors:

Byron D. FORD - Atlanta GA, US
Gregory Ford - Cartersville GA, US

Assignee:

Morehouse School of Medicine - Atlanta GA

International Classification:

C40B 30/04
C12Q 1/48
C12Q 1/34
G01N 33/566

US Classification:

506 9, 435 792, 436501, 435 15, 435 18, 435 71, 435 721

Abstract:

Biomarkers for stroke and methods for their detection are disclosed. In one aspect, the present application discloses biomarkers for the diagnosis of stroke in a subject. In another aspect, the application discloses a method for the diagnosis of stroke in a subject. The method comprises detection of stroke biomarkers in cerebrospinal fluid, blood, serum or PMBCs of a subject. Also disclosed is a kit for the detection of biomarkers for the diagnosis of stroke in a subject.

US Patent:

20140030251, Jan 30, 2014

Filed:

Jul 24, 2012

Appl. No.:

13/556847

Inventors:

Byron D. Ford - Atlanta GA, US
Jonathan Stiles - Powder Springs GA, US
Gregory Ford - Cartersville GA, US

Assignee:

MOREHOUSE SCHOOL OF MEDICINE - Atlanta GA

International Classification:

A61K 38/17
A61P 25/28
A61P 25/00
A61P 29/00
A61P 35/00
A61P 1/04
A61P 11/06
A61P 27/02
A61K 39/395
A61P 1/00

US Classification:

4241301, 514 11, 514 178, 514 179, 514 193, 514 132, 514 17, 514 208

Abstract:

Compositions and methods for preventing or ameliorating tissue damage caused by an inflammatory disorder or pathogenic infections are described. In one aspect, a method for preventing or ameliorating tissue damage caused by an inflammatory disorder or pathogenic infection comprises administering to a subject a therapeutically effective amount of a neuregulin. In another aspect, the composition comprises one or more active agents that: (a) increase expression or activity of a neuregulin; (b) inhibit the expression or activity of CXCL10, STAT3 or HEME; or (c) both (a) and (b).